Pacira BioSciences, Inc. — Director's Dealing 2012

Apr 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-04-03

Reporting Person: PACE GARY W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-03	Common Stock	$11.02	A	10000	Acquired	2022-04-02	Common Stock (10000)	Direct
2012-04-03	Common Stock	$11.02	A	20000	Acquired	2022-04-02	Common Stock (20000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in twelve equal monthly installments, with the first installment being on May 3, 2012.

F2: The option vests and becomes exercisable as to 25% of the option shares on April 3, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.